Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1299-1303

  Lennernäs, Bo ^a   Albertsson, Per ^a   Edgren, Maliha ^b   Nilsson, Sten ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dose volume inhomogeneity corrected biological effective dose; Four dimensional; Linear quadratic; Prostate cancer; Radiotherapy

Indexed keywords

ADENOCARCINOMA; ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; HUMAN; MALE; PROSTATE TUMOR; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RELATIVE BIOLOGIC EFFECTIVENESS; STANDARD; STATISTICAL MODEL;

ADENOCARCINOMA; BRACHYTHERAPY; COMPUTER SIMULATION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MODELS, STATISTICAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 38449096500     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1299     Document Type: Article

References (16)

1. Cancer statistics in Sweden 2005. Socialstyrelsen. http://www.sos.se/sos/ statisti.htm
2. Martinez A, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W and Vicini FA: Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont Phase II dose-escalating trial. Int J Rad Oncol Biol Phys 47: 343-352, 2000. (Pubitemid 30236374)
3. Hanks GE: Radiotherapy or surgery for prostate cancer? Acta Oncol 30: 231-237, 1991.
4. Porter AT and Forman JD: Prostate Brachytherapy, an overview. Cancer 71: 953-958, 1993.
5. Hanks GE, Hanlon AL, Schultheiss TE, et al: Dose escalation with 3D conformal treatments: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41: 501-510, 1998. (Pubitemid 28275077)
6. Lennernas B, Holmang S and Hedelin H: High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center. Strahlenther Onkol 178: 537-541, 2002.
7. Bucci K, Bevan A and Roach M: Advances in radiation therapy: conventional to 3D, to IMRT, to 4D and beyond. Cancer J Clin 55: 117-134, 2005. (Pubitemid 40372906)
8. Lennernäs B and Nilsson S: Calculated effects of displacement errors in external beam radiotherapy of prostatic adenocarcinoma. Acta Oncol 38: 203-208, 1999. (Pubitemid 29179775)
9. Wolbarst AB: Optimization of radiation therapy II: The critical-voxel model. Int J Radiat Oncol Biol Phys 10: 741-745, 1984.
10. Steel CG: Growth kinetics of tumours. Clarendon Press, Oxford, 1977.
11. Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62: 679-694, 1989.
12. King CR and Mayo CS: Is the prostate/ratio of 1.5 from Brenner & Hall a modeling artifact? Int J Rad Oncol Biol Phys 47: 536-538, 2000.
13. Brenner DJ and Hall EJ: Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Rad Oncol Biol Phys 43: 1095-1101, 1999. (Pubitemid 29144800)
14. Lai PP, Perez CA, Shapio SJ and Lockett MA: Carcinoma of the prostate stage B and C: Lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int J Radiat Oncol Biol Phys 19: 561-568, 1990. (Pubitemid 20324247)
15. Eklöv S, Essand M, Carlsson J and Nilsson S: Radiation sensitization by Estramustine. Studies on cultured human prostatic cancer cells. Prostate 21: 287-295, 1992. (Pubitemid 23045291)
16. DeWeese T, Dillehay LE, Shao Y and Williams JR: Low dose sensitization of human prostate cancer cells. Int J Radiat Oncol Biol Phys 30 (Suppl): 319, 1994.